Matches 251 - 300 out of 395 < 1 2 3 4 5 6 7 8 >
Match Document Document Title
5656277 Nor- and homo- bile acids derivatives as absorption enhancers for medicaments  
The use of nor- and homo-bile acids derivatives as absorption enhancers for medicaments is described. Said derivatives show the advantage of improving the absorption of medicaments through mucosae...
5643884 Lupane triterpenoid derivatives  
This invention relates generally to the field of medicinal chemistry, and more specifically to derivatives of a subclass of triterpenoid acids that have multi-medicament properties, that is...
5643889 Cholesterol conjugates of 2'5'-oligoadenylate derivatives and antiviral uses thereof  
A cholesterol-cordycepin conjugate having the formula ##STR1## wherein: n is an integer from 1 to 8; R 1 is selected from the group of consisting of T, T' and Y; T is ##STR2## T' is ##STR3## where...
5643898 Combination of derivatives of pyrimidine and of hydrocortisone for inducing and stimulating the growth of hair and reducing its loss  
1. Combination intended to induce and to stimulate the growth of hair and to reduce its loss, characterized in that it comprises: a) a component (A) containing, in an anhydrous, physiologically...
5641765 17-αand 17-βsubstituted acyl-3-carboxy-3,5-dienes and use in inhibiting 5-α-reductase  
Invented are 17α and 17β-substituted acyl-3-carboxy-3,5-diene analogues of steroidal synthetic compounds, pharmaceutical compositions containing these compounds, and methods for using these...
5637310 Method of treating prostatic adenocarcinoma  
Invented is a Method of Treating Prostatic Adenocarcinoma by employing asteroid 5-α-reductase inhibiting compound or a combination of steroid 5-α-reductase inhibiting compounds.
5618806 17α and 17β-substituted estra-1,3,5(10)-triene-3-carbboxlic acid  
Invented are 17α and 17β-substituted acyl-3-carboxy aromatic A ring analogues of steroidal synthetic compounds. Representative of such compounds include the following ##STR1## wherein Z is α or...
5609873 Use of an ecdysteroid for the preparation of cosmetic or dermatological compositions intended, in particular, for strengthening the water barrier function of the skin or for the preparation of a skin cell culture medium, as well as to the compositions  
The invention relates to a cosmetic or dermatological composition, as well as a cell culture medium. This composition and this medium contain an ecdysteroid, an ecdysteroid derivative or a plant or...
5610149 Steroidal polyamines  
New steroidal polyamines have the structure of formula I or formula II: ##STR1## wherein R 1 and R 2 are independently N(R') 3 + or H in the α- or β- position except both R 1 and R 2 are...
5607691 Compositions and methods for enhanced drug delivery  
The present invention relates to methods of delivering pharmaceutical agents across membranes, including the skin layer or mucosal membranes of a patient. A pharmaceutical agent is covalently...
5603935 Composition for the treatment of snoring and methods of use thereof  
A composition and method for the treatment of snoring comprising an effective amount of discorea villosa and zingiber officinale in a physiologically acceptable carrier, to be administered in the...
5604216 Compositions containing esters of unsaturated fatty acids  
Pharmaceutical and nutritional compositions are disclosed containing, in association with a suitable diluent or carrier, at least 10% by weight of a cholesterol fatty acid ester where the fatty...
5591733 Methods, compositions, and compounds for allosteric modulation of the gaba receptor by members of the androstane and pregnane series  
Method, compositions, and compounds for modulating brain excitability to alleviate stress, anxiety, insomnia and seizure activity using certain steroid derivatives that act at a newly identified...
5587368 Administration of a 27-hydroxycholesterol or related compound or sterol-27-hydroxylase stimulant to prevent restenosis following vascular endothelial injury  
A method for preventing or reducing restenosis wherein a 27-hydroxycholesterol or a 25,26 and/or 27-aminocholesterol, or a sterol 27-hydroxylase stimulant, is administered in a restenosis...
5582828 Active fractions of Cordyceps sinensis and method of isolation thereof  
A method for identifying and isolating the active fractions in Cordyceps sinensis. It covers a findings of the structure of an active compound that is present in the active fraction, an isolation...
5574022 Method of attenuating physical damage to the spinal cord  
A method is disclosed for attenuation of nervous system damage after injury which comprises administering therapeutic amounts of PREG, PREG-S, or esters of PREG or PREG-S together with an enhancer...
5567694 17-Aryl and 17-heterocyclyl-5β,14β-androstane derivatives active on the cardiovascular system, processes for their preparation and pharmaceutical compositions containing same  
17-aryl and heterocyclyl-5β,14β-androstane compounds having the formula (I) ##STR1## wherein R is an aryl ring or a saturated or unsaturated heterocyclic ring are active on the cardiovascular...
5565443 Subcutaneous implants based on normegestrol derivatives  
Subcutaneous implant for preventing conception for at least one year in women comprising an amount effect to prevent conception without suppressing intermontly bleeding of a steroid compound of...
5561124 17-α-acyl steroids which inhibit 5-α-reductase  
The invention relates to substituted 17α-acyl steroidal 5α-reductase inhibiting compounds. The invention also relates to pharmaceutical compositions containing these compounds and their use for...
5556644 Nutritional supplement for the elderly  
A multinutrient nutritional supplement is provided that is designed to be most effective in increasing the immunity and decreasing the instances and severity of infection particularly among older...
5554386 Delivery of therapeutic agents to receptors using polysaccharides  
This invention relates to a method of directing a therapeutic agent to selected cells, wherein a complex is formed between a polysaccharide capable of interacting with a cell receptor and a...
5550107 Combination therapy for the treatment of estrogen-sensitive disease  
A method of treatment of breast and endometrial cancer in susceptible warm-blooded animals may include inhibition of ovarian hormonal secretion by surgical (ovariectomy) or chemical (use of an LHRH...
5550120 Regulating neuropeptide hormone secretion  
Methods are described for regulating neuropeptide secretion to alleviate premature labor, hypertension, fluid imbalance, and risk of heart disease: using neuroactive steroids targeted for a...
5545634 Activation of androgen receptors with low dose non-masculinizing androgenic compounds  
A method of treatment or prevention of breast and endometrial cancer, osteoporosis and endometriosis in susceptible warm-blooded animals comprising administering a low dose. Of a progestin or other...
5538721 Stabilization of aminosteroids for topical ophthalmic and other applications  
The invention provides methods for stabilizing amino-substituted steroid therapeutic agents in topical ophthalmic and other pharmaceutical formulations using effective stabilizing amounts of...
5534505 Ursodeoxycholic acid-containing medicament in a liquid adminstration form  
The active agent ursodeoxycholic acid has proved therapeutically active in infants, inter alia for the treatment of cholestatic hepatic diseases. A problem when administering this active agent, a...
5527788 Method and composition for treating obesity comprising dehydroepiandrosterone (DHEA), or a derivative thereof, and an anorectic agent  
The invention describes a method and composition for treating obesity or related disorders in animals using an anorectic agent and dehydroepiandrosterone (DHEA). The composition effectively...
5525349 Compositions and methods for treating the cornea inconjunction with laser irradiation  
Methods for preventing and treating corneal haze resulting from exposure of the eye to laser irradiation are disclosed. The methods include administration of compositions of wound healing...
5514667 Method for topical treatment of herpes infections  
A method for the topical treatment of herpes virus infections of the skin and mucous membranes is disclosed- This method uses a topical preparation comprising an anti-vital drug in combination with...
5512556 Use of a pregnane derivative  
The invention relates to a use of pregnane derivatives of the following general formula: ##STR1## in which R=H 2 , (H,OH), (H,OAcyl), or O, and especially the pregnane...
5480913 Anti-androgen compounds  
Disclosed are novel classes of anti-androgens including dihydrophenanthrene derivatives, their method of synthesis and their use in treating disorders associated with excessive androgenic activities.
5439899 Cosalane and related compounds having activity against aids and aids-related infections  
Novel compounds having anti-HIV activity are disclosed along with formulations and methods for treating human immunodeficiency viral infections employing these compounds.
5439685 Pharmaceutical composition for the prevention of sexually transmitted diseases  
A pharmaceutical composition for the prevention of sexually transmitted diseases, intended to be contacted with a mucosa. The composition contains, on the one hand, at least one constituent active...
5422393 Natriuretic hormone  
A purified naturally occurring natriuretic compound, identified as Natriuretic Hormone, and a method for isolation of the compound. The natriuretic compound has a molecular weight of about 360, a...
5403590 Method of pulsatile drug infusion  
A method of pulsatile infusion of a drug or other therapeutic agent is described. The pulsatile infusion method minimizes tachyphylaxis, while enabling the target cell, tissue, or organ to benefit...
5397563 Perfluoro-t-butyl-containing steroids for use in fluorine-19 NMR and/or MRI  
Accordingly, the present invention is directed to biological compounds derivatized so as to contain at least one perfluoro-t-butyl moiety for use in fluorine-19 NMR and/or MRI studies. The...
5393513 Stable, highly concentrated fluoro carbon emulsions  
A non-toxic, brominated perfluorocarbon emulsion for internal and intravenous use in animals (including humans) is disclosed, for use as an oxygen transport medium and as a contrast enhancement...
5389623 Redox carriers for brain-specific drug delivery  
Compounds of the formula ##STR1## and the nontoxic pharmaceutically acceptable salt thereof, wherein D is the residue of a centrally acting drug containing at least one reactive functional group...
5382434 Low steroid dose dry pharmaceutical preparation  
Disclosed are dry pharmaceutical preparations containing potent steroidal medicinal agents in combination with an excipient capable of binding the agent to an extent greater than 80% and a having a...
5376641 Method for making a steroid water soluble  
A complex of branched beta cyclodextrin and steroid is formed by mixing a steroid and a branched beta cyclodextrin together in water for a period of about 4 to 24 hours under ambient conditions....
5362720 Methods of treating or preventing breast or endometrial cancer with low dose non-masculinizing androgenic compounds  
A method of treatment or prevention of breast and endometrial cancer, osteoporosis and endometriosis in susceptible warm-blooded animals comprising administering a low dose of a progestin or other...
5356881 Plant-derived wildlife repellents  
Products from the plant species Nerium oleander and, Urginea maritima, are prepared and tested as wildlife repellents comparing them with digitalis products. Chemical compounds derived from these...
5344826 Tricycle steroid analogs  
Novel tricyclic steriod analogs are disclosed which are 1H-benz[e]indene dodecahydro compounds that are useful for enhancing GABA-induced chloride currents at the GABA receptor/chloride ionophore...
5344827 Steroid sulphatas inhibitors  
Novel steroid 3-thiophosphonates are disclosed which are useful as steroid sulphatase inhibitors.
5336506 Targeting of therapeutic agents using polysaccharides  
The invention relates to a method for the targeting of a therapeutic agent to a specific population of cells, wherein a complex is formed between the therapeutic agent and a polysaccharide capable...
5324719 Therapeutical method for the treatment of hypertension  
A therapeutical method for treating hypertension is disclosed which comprises administering to a patient in need thereof an effective amount of an imino derivative of 3β,...
5321018 Use of 1α-hydroxylated-19-nor-vitamin D compounds to treat psoriasis  
A novel use for 1α-hydroxylated-19-nor-vitamin D compounds to treat psoriasis inasmuch as these compounds when administered to humans are converted to a metabolite, such as a 1α,25-dihydroxylated...
5321019 Bile acid sulfurated derivatives  
Compounds of formula I: ##STR1## in which the various R groups have the meanings defined in the disclosure are useful as medicaments for the treatment of hepatobiliary diseases.
RE34578 Drugs for topical application of sex steroids in the treatment of dry eye syndrome, and methods of preparation and application  
A topical drug application for the alleviation of kerato-conjunctivitis sicca (dry eye syndrome) is comprised of a solution of sex steroids or their derivatives suspended or dissolved in a vehicle,...
5292730 Modulation of immune system with Δ5-androstenes  
Alzheimer's disease and immune deficiency disorders may be effectively treated by administering a Δ5-Androstene-3β-ol-17-one having a C 7 substituent selected from the group consisting of oxo,...
Matches 251 - 300 out of 395 < 1 2 3 4 5 6 7 8 >